-
-
-
-
-
-
-
SANOFI AND ABLYNX ANNOUNCE THE SUCCESSFUL RESULTS OF THE INITIAL TENDER OFFER PERIOD FOR ABLYNX AND COMMENCEMENT OF SQUEEZE-OUT TENDER PERIOD
-
-
-
-
-
-
-
ABLYNX ANNOUNCES TOPLINE RESULTS FROM THE PHASE II STUDY OF VOBARILIZUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
-
-
-
-
-
5,309 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

